Trials / Completed
CompletedNCT06766084
Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,878 (actual)
- Sponsor
- Technion, Israel Institute of Technology · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Retrospective study of adult patients with multivessel disease undergoing isolated coronary artery bypass grafting (CABG) in three centers between January 1st, 2009, and December 31st, 2023. Patients were grouped according to the revascularization strategy (total arterial revascularization vs. multiarterial grafting). Primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CABG | All patients underwent isolated CABG and retrospectively followed to asses clinical outcomes of the two different revascularization techniques |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2025-01-09
- Last updated
- 2025-01-09
Source: ClinicalTrials.gov record NCT06766084. Inclusion in this directory is not an endorsement.